CLINICAL_TRIALS
trial_result
· 2024-11-06
Clinical Trial Update: The Intracerebral Hemorrhage Acutely Decreasing Arterial Pressure Trial II [Phase 2]
Summary
Phase 2 trial investigating acute arterial pressure reduction for intracerebral hemorrhage has been terminated. Sponsor: University of Alberta.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Alberta | Conditions: Intracerebral Hemorrhage | Phase 2 | Status: TERMINATED